ASH is just over a month away. Come meet with the GTC team and its co-op partners at our happy hour event.
Download your invitation Here
Case Study: VEXAS Syndrome
Background VEXAS syndrome is a disease with inflammatory and hematologic (blood) manifestations. The syndrome is caused by mutations in the UBA1 gene affecting the Met41 residue of the protein and resulting in
June 8, 2022